ImmuPharma plc (LON:IMM – Get Free Report)’s share price traded up 11.7% during mid-day trading on Tuesday . The stock traded as high as GBX 4.39 ($0.06) and last traded at GBX 4.38 ($0.06). 5,453,036 shares traded hands during mid-day trading, a decline of 71% from the average session volume of 18,661,518 shares. The stock had previously closed at GBX 3.92 ($0.05).
ImmuPharma Stock Performance
The company’s fifty day moving average is GBX 3.04 and its 200-day moving average is GBX 2.11. The company has a market capitalization of £20.83 million, a PE ratio of -8.47 and a beta of 1.53.
About ImmuPharma
ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.
Featured Articles
- Five stocks we like better than ImmuPharma
- How to Invest in Blue Chip Stocks
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- Market Cap Calculator: How to Calculate Market Cap
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- The 3 Best Blue-Chip Stocks to Buy Now
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
